ASX:EYE Nova Eye Medical (EYE) Stock Price, News & Analysis → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free EYE Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield1.23%Price TargetN/A Stock AnalysisStock Analysis Get Nova Eye Medical alerts: Email Address Ad Vertical Research Advisory“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… About Nova Eye Medical Stock (ASX:EYE)Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.Read More Ad Vertical Research Advisory“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… EYE Stock News HeadlinesMarch 28, 2024 | msn.comNova Scotia sees 35 per cent cut in international student permit applications in 2024March 28, 2024 | msn.comDogs can detect trauma stress by smelling humans' breath, study showsMarch 28, 2024 | Vertical Research Advisory (Ad)“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!March 24, 2024 | sports.yahoo.comState of Sports: It's been an interesting journey to stardom for SNHU's BechtMarch 23, 2024 | finance.yahoo.comNewsflash: Nova Eye Medical Limited (ASX:EYE) Analysts Have Been Trimming Their Revenue ForecastsMarch 22, 2024 | ca.news.yahoo.comNova Scotia strikes deal with private company for renovated health centreMarch 21, 2024 | au.news.yahoo.comNova Scotia Teachers Union to hold strike vote April 11March 16, 2024 | ca.news.yahoo.comPatients relocated due to water leak at Halifax health facilityMarch 28, 2024 | Vertical Research Advisory (Ad)“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!March 15, 2024 | msn.com‘Feisty’ furless raccoon creates quite the buzz at N.S. wildlife rehab centreMarch 15, 2024 | news.yahoo.com‘New’ star to be visible in once-in-a-lifetime event due to rare Nova explosion: NASAMarch 14, 2024 | msn.comSolar eclipse: Avoid eye damage with these precautionsMarch 12, 2024 | msn.comMacron faces backlash from medical workers over assisted-dying billMarch 12, 2024 | msn.comRyan Gosling and Eva Mendes: A Look Into Their Private Romance From Co-Stars to Life PartnersMarch 6, 2024 | msn.comStudy identifies conjunctivitis as the most common ocular symptom of COVIDMarch 1, 2024 | msn.comNSU has a secret weapon for athletes trying to go proFebruary 29, 2024 | cnet.comCasper Axes Wave and Nova, in Favor of New Dream and Snow MattressesFebruary 26, 2024 | msn.com32 TV Shows That Shouldn’t Have Been Cancelled After Just One SeasonFebruary 23, 2024 | ca.news.yahoo.comWorker dead after incident on Clearwater Seafoods vessel out of Mulgrave, N.S.February 23, 2024 | msn.comI Used My Mattress Expertise to Identify 10 Mattresses Blindfolded. Here's How I Did ItFebruary 22, 2024 | ca.news.yahoo.comSurvivors of October 7 Hamas assault sue AP for hiring freelance photographers ‘embedded with terrorists’February 22, 2024 | dailymail.co.ukHorrifying new report into October 7 rapes reveals how survivors walked through 'an apocalypse of bodies' missing body parts, while one victim had a GRENADE inserted into her ...February 22, 2024 | ca.news.yahoo.comNova Scotia's Lobster Crawl features this amazing poutine upgradeFebruary 22, 2024 | finance.yahoo.comGlobal Continuing Medical Education Market Outlook Report 2023-2028 - Increasing Demand for Short-Term CME CoursesFebruary 22, 2024 | ca.news.yahoo.comNova Scotia Health to lift COVID-19 immunization requirement for employeesFebruary 21, 2024 | ca.news.yahoo.comFemale couples can now register as parents on newborn's birth certificate in Nova ScotiaFebruary 10, 2024 | finance.yahoo.comHere's Why We're Not Too Worried About Nova Eye Medical's (ASX:EYE) Cash Burn SituationSee More Headlines Receive EYE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nova Eye Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:EYE CUSIPN/A CIKN/A Webwww.ellex.com Phone61 8 7074 8200FaxN/AEmployees12,792Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,310,000.00 Net Margins-76.24% Pretax MarginN/A Return on Equity-68.36% Return on Assets-23.09% Debt Debt-to-Equity Ratio7.14 Current Ratio1.47 Quick Ratio3.05 Sales & Book Value Annual Sales$18.77 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.09 per share Price / BookN/AMiscellaneous Outstanding Shares228,800,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.93 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Victor Previn B.E. (Age 66)B.Eng, Founder & Executive Chairman Comp: $236.84kMr. Thomas H. Spurling AM (Age 62)BSc (Hons), FRACI, FTSE, Ph.D., MD & Executive Director Comp: $252.55kLiam CookChief Financial OfficerMr. Keith ByrneVice President of Global OperationsMark FlynnInvestor RelationsMs. Kate HuntHead of MarketingDr. David Lubeck M.D.Chief Medical OfficerMr. Joaquin V. Wolff (Age 66)President of Ellex iTrack Ms. Kimberley MenziesGroup Financial Controller & Global Finance ManagerMr. Simon Jeremy Newton Gray BEc (Age 65)C.A., CA, Company Secretary More ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersRahmon CoupeSold 149,022 sharesTotal: $31,294.62 ($0.21/share)Rahmon CoupeBought 277,778 shares on 5/5/2023Total: $50,000.04 ($0.18/share) This page (ASX:EYE) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nova Eye Medical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.